Market Cap

Neurocrine Biosciences, Inc. Market Capitalization:

$13.91 Billion

USD as of July 1, 2024

business Neurocrine Biosciences, Inc. Company Profile

Neurocrine Biosciences, Inc. Main Stock Listing

NASDAQ: NBIX

Market Capitalization History of Neurocrine Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Neurocrine Biosciences, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $13.12 B 11.04%
Jan. 1, 2023 $11.82 B 55.69%
Jan. 1, 2022 $7.59 B -28.00%
Jan. 1, 2021 $10.54 B 9.66%
Jan. 1, 2020 $9.61 B 13.44%
Jan. 1, 2019 $8.48 B 3.22%
Jan. 1, 2018 $8.21 B 99.18%
Jan. 1, 2017 $4.12 B 0.85%
Jan. 1, 2016 $4.09 B 26.41%
Jan. 1, 2015 $3.23 B 96.96%
Jan. 1, 2014 $1.64 B 88.63%
Jan. 1, 2013 $870.4 M -2.58%
Jan. 1, 2012 $893.5 M 26.02%
Jan. 1, 2011 $709.0 M 214.04%
Jan. 1, 2010 $225.8 M -29.22%
Jan. 1, 2009 $319.0 M -38.40%
Jan. 1, 2008 $517.8 M -61.44%
Jan. 1, 2007 $1.34 B -77.00%
Jan. 1, 2006 $5.84 B 32.83%
Jan. 1, 2005 $4.40 B -18.97%
Jan. 1, 2004 $5.42 B 30.18%
Jan. 1, 2003 $4.17 B 4.23%
Jan. 1, 2002 $4.00 B 27.54%
Jan. 1, 2001 $3.13 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Neurocrine Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: NBIX

Stock: Bovespa: N1BI34

Stock: FSX: NB3

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.